Showing 1 - 7 results of 7 for search '"transcript levels"', query time: 0.03s Refine Results
  1. 1

    Gasoline fume inhalation induces apoptosis, inflammation, and favors Th2 polarization in C57BL/6 mice by Nour-Eldine, Wared

    Published 2022
    “…The latter was consistent with increases in the transcript levels of proinflammatory cytokines [Interleukins (ILs) 4 and 6], respectively by ~ 6- and 4-fold in the lungs of GE mice compared to CON. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  2. 2

    Comparative Genomic Mapping Implicates LRRK2 for Intellectual Disability and Autism at 12q12, and HDHD1, as Well as PNPLA4, for X-Linked Intellectual Disability at Xp22.31 by Jonathan D. J. Labonne (18090841)

    Published 2020
    “…We propose HDHD1 and PNPLA4 for X-linked intellectual disability in this region, since their high transcript levels in the human brain substantiate their role in intellectual functioning.…”
  3. 3

    G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome by Francesco Casciello (18557613)

    Published 2020
    “…In addition, we show that CDH10 expression is prognostic in breast cancer and that it is inversely correlated to EHMT2 (G9a) transcript levels in many tumor-types, including breast cancer.…”
  4. 4

    A Novel Role Of GATA6 in Rhabdomyosarcoma. (c2016) by Khoury, Michelle Fady El

    Published 2016
    “…The objective of this study is to understand the role of GATA6 in Rhabdomyosarcoma by assessing its expression at the transcriptional level and studying the effect of its down-regulating, by specific siRNA, on cell cycle and cellular proliferation. …”
    Get full text
    Get full text
    Get full text
    masterThesis
  5. 5
  6. 6

    Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients by Mohamed A. Ismail (418629)

    Published 2022
    “…In addition, the BCR-ABL1 transcript level is currently a key predictive biomarker of CML response to treatment with Tyrosine Kinase Inhibitors (TKIs). …”
  7. 7

    Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase by Mohamed A. Yassin (16322749)

    Published 2021
    “…</p> <p>The primary efficacy end point will be the rate of major molecular response at 12 months, defined as a BCR-ABL transcript level of 0.1% or less in peripheral blood on RQ-PCR assay, as expressed on the International Scale. …”